Please login to the form below

Not currently logged in
Email:
Password:

bupropion

This page shows the latest bupropion news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

The EAGLES study - published in The Lancet - backed the safety and efficacy of Pfizer's Chantix/Champix (varenicline) and GlaxoSmithKline's Zyban (bupropion) as well as nicotine replacement therapies in helping

Latest news

More from news
Approximately 4 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics